Monte Financial Group, LLC Baxter International Inc Transaction History

Monte Financial Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$71.57 - $93.3 $339,170 - $442,148	-4,739 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$76.7 - $88.45 $139,977 - $161,421	-1,825 Reduced 27.8%	4,739 $396,000
Q3 2019 Nov 06, 2019	SELL	$81.4 - $89.78 $23,524 - $25,946	-289 Reduced 4.22%	6,564 $574,000
Q2 2019 Aug 07, 2019	BUY	$73.44 - $82.41 $20,122 - $22,580	274 Added 4.16%	6,853 $561,000
Q1 2019 Apr 23, 2019	BUY	$64.48 - $81.31 $41,073 - $51,794	637 Added 10.72%	6,579 $535,000
Q4 2018 Jan 31, 2019	SELL	$61.45 - $77.8 $6,083 - $7,702	-99 Reduced 1.64%	5,942 $391,000
Q3 2018 Oct 16, 2018	SELL	$70.71 - $77.75 $3,394 - $3,732	-48 Reduced 0.79%	6,041 $466,000
Q2 2018 Oct 16, 2018	SELL	$63.43 - $75.41 $16,364 - $19,455	-258 Reduced 4.06%	6,089 $450,000
Q1 2018 Oct 16, 2018	SELL	$62.56 - $72.26 $16,828 - $19,437	-269 Reduced 4.07%	6,347 $413,000
Q4 2017 Oct 16, 2018	BUY	$61.45 - $66.05 $406,553 - $436,986	6,616	6,616 $428,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Monte Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Monte Financial Group, LLC with notifications on news.